About Arrhythmia Monitoring Devices
Arrhythmia monitoring devices are advanced monitoring solutions using telecommunication technologies such as ECG diagnosis. Due to the use of telecommunication for remote diagnosis is growing rapidly. The expansion of ambulatory monitoring technologies affords the clinician the obvious diagnostic advantage of more comprehensive and real-time data.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The global arrhythmia monitoring devices market is highly competitive and consists of some key players. In terms of market share, few of the key players presently dominate the global market. These market players are leveraging on strategic collaborative creativities to intensification their market share and escalation their profitability. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Arrhythmia Monitoring Devices market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
GE Healthcare (United States), Medtronic (Ireland), Abbott Laboratories (St. Jude Medical) (United States), Nihon Kohden (Japan), Philips Healthcare (Netherlands), Hill-Rom (Welch Allyn) (United States), Biotronik (Germany), OSI Systems (Spacelabs Healthcare) (United States), NUUBO Smart Solutions Technologies (Spain) and Fukuda Denshi (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are BioTelemetry (England), Medi-Lynx (United States), St. Jude Medical (Abbott) (United States) and Others.
Segmentation Overview
AMA Research has segmented the market of Global Arrhythmia Monitoring Devices market by , Application (Hospitals & Clinics, Diagnostic Centres, Ambulatory Surgical Centers and Homecare Settings) and Region.
On the basis of geography, the market of Arrhythmia Monitoring Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Online Stores will boost the Arrhythmia Monitoring Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Devices, the sub-segment i.e. ECG will boost the Arrhythmia Monitoring Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Technology Advancement in Arrhythmia Monitoring Devices and High Adoption of Cardiac Arrhythmia Monitoring Devices
Market Growth Drivers:
Increase Number of Arrhythmia Patients across the Globe and Growing Number of Hospitals and Diagnostics Centres in Emerging Regions
Challenges:
Less Awareness among Consumers
Restraints:
High Manufacturing Cost and Rapid Changes in Technology
Opportunities:
Growing Number of Device Manufacturing Companies in China and Japan
Market Leaders and their expansionary development strategies
In November 2021, Philips agreed to acquired Cardiologs, a France-based medical technology company focused on cardiac diagnostics using AI and cloud technology.
In October 2023, Boston Scientific announced the FDA clearance and launch of its next-generation insertable cardiac monitor for long-term monitoring of arrhythmias associated with atrial fibrillation, cryptogenic stroke and syncope.
Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Arrhythmia monitoring devices Manufacturers, Suppliers, and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.